In nasopharyngeal cancer, it was shown that tumor-derived ExoPD-L1 promotes immune escape by inhibiting the activity of CD8+ T cells through the interaction of ExoPD-L1 with the PD-1 on the surface of T cells [38]. Here, CD8A is linked to neoplasm.